Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation Post author:Sam Post published:November 29, 2017 Post category:BioPharma Genmab just received a $20M milestone payment from Janssen Biotech. Source: BioSpace You Might Also Like ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2 September 10, 2017 PDL BioPharma Gives Up on Acquiring Neos Therapeutics February 19, 2018 BioTelemetry Reaches Key Milestone In Tender Offer For LifeWatch Corp June 8, 2017
ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2 September 10, 2017
